Dow Down 0.41% Nasdaq Down 0.70%

Novavax, Inc. (NVAX)

-NasdaqGS
4.03 Down 0.09(2.19%) 11:03AM EDT - Nasdaq Real Time Price
Prev Close:4.12
Open:4.10
Bid:4.05 x 3200
Ask:4.06 x 7700
1y Target Est:10.58
Beta:1.04
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.01 - 4.18
52wk Range:2.68 - 6.95
Volume:698,377
Avg Vol (3m):2,977,580
Market Cap:959.53M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVAX

Comparison

Symbol% ChgMkt Cap
NVAXDown 2.19%959.53M
MRKDown 0.15%169.10B
NVSUp 0.01%226.20B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):33.51
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.07
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback